Huntington's NSW

1800 244 735

Helpline (02) 9874 9777

Research articles

Click here to read our latest research articles.

 

HDBuzz is a collaboration of scientists who write Huntington’s disease research news in plain language for the global HD community.
They have allowed us to retrieve their articles for the NSW ACT Huntington’s community.

 

Global research collaboration

The Huntington Study Group (HSG), is the world’s first HD cooperative therapeutic research organization. Today, HSG is a world leader in facilitating high quality clinical research trials and studies that bring us closer to finding more effective treatments for HD and reducing the burden of HD for families affected by the disease.

HSG is an organization of compassionate professionals dedicated to finding treatments that make a difference, providing rigorous care initiatives, and improving the quality of life and outcomes for HD families. How? By bringing together families, medical professionals, clinical researchers, HD advocacy groups, and sponsors to raise awareness of HD, share knowledge and best practices, and develop innovative treatments.

Words from HSG website.

How NSW contributes to research

More information coming soon.

Share on facebook
Share on twitter
Share on pinterest
Share on email

HD Young Adult Study defines the sweet spot: symptom-free with measurable changes

Published date: 27 May, 2020

A new study headed up by Dr. Sarah Tabrizi, a pioneer in HD research, assessed pre-manifest HD young adults many years from predicted symptom onset with a battery of clinical tests. The goal of this study was to identify a sweet spot – a time when HD participants weren’t experiencing any observable symptoms, but when ... Read more
READ MORE >

Fountain of youth: HTT protein repairs neurons by maintaining youthful state

Published date: 13 May, 2020

A team of scientists has recently published their findings on how our bodies are able to repair brain and spinal cord injuries. They found that the huntingtin protein plays an important role in repairing damaged nerve cells. Repairing nervous system damage – the holy grail of medical science It has long been the ambition of ... Read more
READ MORE >
Light and sleep

Light and Sleep

Published date: 7 April, 2020

Light & sleep Neurofilament Light Protein and Lifestyle Factors Commentary Words Dr Travis Cruickshank and Dr Danielle Bartlett
READ MORE >

New molecule can reverse the Huntington's disease mutation in lab models

Published date: 6 April, 2020

A collaborative team of scientists from Canada and Japan have identified a small molecule which can change the CAG-repeat length in different lab models of Huntington’s disease. CAG repeats are unstable Huntington’s disease is caused by a stretch of C, A and G chemical letters in the Huntingtin gene, which are repeated over and over ... Read more
READ MORE >

What does COVID-19 mean for Huntington’s disease families and HD research?

Published date: 6 April, 2020

COVID-19, short for coronavirus disease 2019, has taken the world by storm in almost every sense – many people have been infected with the SARS-CoV-2 virus, it’s created shopping pandemonium in stores, and many people are isolated at home. But behind that frenzied storm, scientists around the world have been working tirelessly to move research ... Read more
READ MORE >

Huntington’s disease therapeutics conference 2020 – Day 1

Published date: 12 March, 2020

Our new writers Rachel Harding and Sarah Hernandez report from the Huntington’s Disease Therapeutics Conference – the biggest annual gathering of HD researchers.
READ MORE >

THE LATEST HD SCIENCE

Published date: 4 March, 2020

Change to the design of Roche’s ongoing huntingtin lowering trial – known as the GENERATION HD1 study The pharmaceutical giant Roche ran an earlier, smaller, study with antisense oligonucleotides or ASOs as potential HD treatments. That was a safety study – designed to determine whether or not giving ASOs via the spinal fluid led to ... Read more
READ MORE >

Huntington’s disease therapeutics conference 2020 – Day 3

Published date: 3 March, 2020

Rachel and Sarah report from the Huntington’s Disease Therapeutics Conference – the biggest annual gathering of HD researchers. Be sure to catch up on Day 1 and Day 2. Thursday morning – Huntingtin lowering Good morning everyone! We are back for Day 3 at the CHDI meeting in Palm Springs which is all about huntingtin ... Read more
READ MORE >

Huntington’s disease therapeutics conference 2020 – Day 2

Published date: 1 March, 2020

Rachel and Sarah report from the Huntington’s Disease Therapeutics Conference – the biggest annual gathering of HD researchers. Be sure to catch up on Day 1! Good morning everyone! We are back for day 2 of the CHDI therapeutics conference in Palm Springs. Lots of exciting talks coming up! Wednesday morning – The path to ... Read more
READ MORE >

Screening the entire genome for new drug targets for HD

Published date: 23 February, 2020

A recently published study in the journal ‘Neuron’ has identified new potential therapeutic targets for the treatment of Huntington’s disease (HD). The work conducted by Professor Myriam Heiman and colleagues used cutting-edge genetic technologies and discovered several genes could modify HD progression in their models in the lab. Many of these genes have not been ... Read more
READ MORE >

QUICKLINKS

RESOURCES LIBRARY

Huntington's NSW ACT Office

NDIS Registered Provider logo

Helpline (02) 9874 9777  

BECOME A MEMBER
DONATE

© Huntington’s NSW & ACT Inc. 2020 | Legal Disclaimer & Privacy Policy | Sitemap

Huntington’s NSW ACT acknowledges the Australian Aboriginal and Torres Strait Islander peoples as the first inhabitants of the nation and the traditional custodians of the lands where we live, learn and work.
Huntington’s NSW ACT is committed to embracing diversity and eliminating all forms of discrimination. Huntington’s NSW ACT welcomes all people irrespective of ethnicity, lifestyle choice, faith, sexual orientation and gender identity.

Made by Marameo Design